-
FDA committee recommends approval of Abbott's Trilipix, statin combination
ABBOTT PARK, Ill. — A Food and Drug Administration advisory committee has voted to recommend that the FDA retain approval of an Abbott drug for high cholesterol in combination with a statin.
The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee met Thursday to discuss whether to recommend continued FDA approval of Trilipix (fenofibric acid) in combination with simvastatin in patients with mixed dyslipidemia and a high risk of heart disease. The FDA is not bound by advisory committee votes, but usually follows them.
-
Water Quality and Health Council raising awareness of swimmer's ear with free pool test kits
ATLANTA — Swimmer’s ear accounts for as many as 2.4 million doctor visits and nearly $500 million in healthcare costs annually, a Centers for Disease Control and Prevention report published Thursday in its "Morbidity and Mortality Weekly Report" found.